APC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_APC_090507
C57BL/6 mouse splenocytes stained with RA3-6B2 APC
  • RA3-6B2_APC_090507
    C57BL/6 mouse splenocytes stained with RA3-6B2 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103211 25 µg $28
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103212 100 µg $88
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45R antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  2. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  3. Noir S, et al. 2017. Nucleic Acids Res. 10.1093/nar/gkx203. PubMed
  4. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Hirata Y, et al. 2010. Blood. 115:3930. PubMed
  7. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  8. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  9. He R, et al. 2021. J Immunol. 206:2353. PubMed
  10. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  11. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  12. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  13. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  14. Li Y, et al. 2016. Nat Commun. 7:10836. PubMed
  15. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  16. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  17. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  18. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  19. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  20. Ma Z, et al. 2016. Clin Cancer Res. 22: 2969 - 2980. PubMed
  21. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  22. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  23. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  24. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  25. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  26. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  27. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  28. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  29. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  30. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  31. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  32. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  33. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  34. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  35. Cunningham C, et al. 2016. PLoS Pathog. 12: 1005356. PubMed
  36. Rothweiler S, et al. 2019. Purinergic Signal. 0.885416667. PubMed
  37. Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
  38. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  39. Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed
  40. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  41. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  42. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  43. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  44. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  45. Perfilyeva Y, et al. 2017. Inflammation Research. 10.1007/s00011-017-1052-4. PubMed
  46. Recher M, et al. 2012. Blood. 119:2819. PubMed
  47. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  48. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  49. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  50. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  51. Reddi RN, et al. 2021. J Am Chem Soc. 143:4979. PubMed
  52. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  53. Li J, et al. 2020. Elife. 9:00. PubMed
  54. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  55. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  56. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  57. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  58. Cervantes-Barragan L, et al. 2007. Blood . 109:1131. PubMed
  59. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  60. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  61. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  62. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  63. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  64. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  65. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  66. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  67. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  68. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  69. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  70. Reddi RN, et al. 2021. J Am Chem Soc. 143:20095. PubMed
  71. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  72. Saintamand A, et al. 2016. Nat Commun. 7:10730. PubMed
  73. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  74. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  75. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  76. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  77. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  78. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  79. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  80. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  81. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  82. Braikia F, et al. 2015. Mol Cell Biol. 35: 3370 - 3380. PubMed
  83. Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed
  84. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  85. Clemens E, et al. 2015. J Immunol. 194:898. PubMed
  86. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  87. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  88. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  89. Ma K, et al. 2022. iScience. 25:104347. PubMed
  90. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  91. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  92. Sun S, et al. 2013. J Immunol. 190:6209. PubMed
  93. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  94. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  95. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  96. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  97. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  98. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  99. Shih F, et al. 2006. J Immunol. 176:3438. PubMed
  100. Zhu D, et al. 2017. Stem Cell Res Ther. 0.511805556. PubMed
  101. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  102. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  103. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  104. Yammani R, et al. 2015. J Immunol. 193: 5434-5443. PubMed
  105. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  106. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  107. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  108. Graf R et al. 2019. Cell reports. 26(5):1098-1103 . PubMed
  109. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  110. Escolano A, et al. 2019. Nature. 570:468. PubMed
  111. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  112. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  113. Fahey L, et al. 2011. J Exp Med. 208:987. PubMed
  114. Koide S, et al. 2022. iScience. 25:103603. PubMed
  115. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  116. Laubreton D, et al. 2020. Viruses. 12:00. PubMed
  117. Feldman S, et al. 2015. J Immunol. 194:2380. PubMed
  118. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  119. Kim SK, et al. 2018. Genes Dev. 32:849. PubMed
  120. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  121. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  122. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  123. Puget N, et al. 2015. Mol Cell Biol. 35:529. PubMed
  124. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  125. Odeh A Simecka J 2016. PLoS One. 11: 0155648. PubMed
  126. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  127. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  128. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  129. Bussey KA, et al. 2019. J Virol. 93. PubMed
  130. Li X, et al. 2018. Immunity. 48:530. PubMed
  131. Li C, et al. 2021. Chem Biol Drug Des. 97:1151. PubMed
  132. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  133. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  134. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  135. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  136. Cooley L, et al. 2016. Sci Rep. 6: 25840. PubMed
  137. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  138. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  139. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  140. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  141. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  142. Perper SJ, et al. 2019. J Immunol. 203:58. PubMed
  143. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  144. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  145. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  146. Man N, et al. 2021. JCI Insight. 6:. PubMed
  147. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
  148. Schaum N, et al. 2020. Nature. 583:596. PubMed
  149. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  150. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  151. Hohmann A, et al. 2016. Nat Chem Biol. 10.1038/nchembio.2115. PubMed
  152. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  153. Zhang Y, et al. 2008. Mol Cell Biol. 28:1688. PubMed
  154. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
RRID
AB_312996 (BioLegend Cat. No. 103211)
AB_312997 (BioLegend Cat. No. 103212)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F, FC, 3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC, IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC, CyTOF®, IHC-F, IHC-P, IP, Activ
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC, IHC-F, 3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC, IHC-F, 3D IHC, SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC, IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC, IHC-F, SB
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC, CyTOF®
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC, CyTOF®, IHC-F, IHC-P, IP, Activ
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 594 anti-mouse/human CD45R/B220

  • APC anti-mouse/human CD45R/B220

  • Biotin anti-mouse/human CD45R/B220

  • FITC anti-mouse/human CD45R/B220

  • PE anti-mouse/human CD45R/B220

  • PE/Cyanine5 anti-mouse/human CD45R/B220

  • Purified anti-mouse/human CD45R/B220

  • PE/Cyanine7 anti-mouse/human CD45R/B220

  • APC/Cyanine7 anti-mouse/human CD45R/B220

  • Alexa Fluor® 488 anti-mouse/human CD45R/B220

  • Alexa Fluor® 647 anti-mouse/human CD45R/B220

  • Pacific Blue™ anti-mouse/human CD45R/B220

  • Alexa Fluor® 700 anti-mouse/human CD45R/B220

  • PerCP anti-mouse/human CD45R/B220

  • PerCP/Cyanine5.5 anti-mouse/human CD45R/B220

  • Brilliant Violet 421™ anti-mouse/human CD45R/B220

  • Brilliant Violet 570™ anti-mouse/human CD45R/B220

  • Brilliant Violet 650™ anti-mouse/human CD45R/B220

  • Brilliant Violet 605™ anti-mouse/human CD45R/B220

  • Brilliant Violet 785™ anti-mouse/human CD45R/B220

  • Brilliant Violet 510™ anti-mouse/human CD45R/B220

  • Purified anti-mouse/human CD45R/B220 (Maxpar® Ready)

  • Brilliant Violet 711™ anti-mouse/human CD45R/B220

  • PE/Dazzle™ 594 anti-mouse/human CD45R/B220

  • APC/Fire™ 750 anti-mouse/human CD45R/B220

  • Brilliant Violet 750™ anti-mouse/human CD45R/B220

  • TotalSeq™-A0103 anti-mouse/human CD45R/B220

  • Spark Blue™ 550 anti-mouse/human CD45R/B220

  • Spark NIR™ 685 anti-mouse/human CD45R/B220

  • TotalSeq™-B0103 anti-mouse/human CD45R/B220

  • Ultra-LEAF™ Purified anti-mouse/human CD45R/B220

  • TotalSeq™-C0103 anti-mouse/human CD45R/B220

  • PE/Fire™ 640 anti-mouse/human CD45R/B220

  • APC/Fire™ 810 anti-mouse/human CD45R/B220

  • PE/Fire™ 700 anti-mouse/human CD45R/B220

  • Spark Violet™ 538 anti-mouse/human CD45R/B220

  • Spark YG™ 581 anti-mouse/human CD45R/B220

  • Spark YG™ 570 anti-mouse/human CD45R/B220

  • PE/Fire™ 810 anti-mouse/human CD45R/B220

  • Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody

  • Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody

  • Spark Red™ 718 anti-mouse/human CD45R/B220

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account